THC2 Polyclonal Antibody

MASTL encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus.

The THC2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of the THC2 protein in various biological samples. This antibody has been extensively validated and exhibits exceptional sensitivity and specificity, ensuring accurate and reproducible results.

The THC2 Polyclonal Antibody is produced using state-of-the-art techniques, guaranteeing high purity and batch-to-batch consistency. It is derived from a host animal that has been immunized with a synthetic peptide corresponding to a unique epitope of the THC2 protein. This antibody recognizes the target protein with high affinity, enabling precise and efficient detection.

With its broad applicability, the THC2 Polyclonal Antibody is suitable for use in various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It is compatible with a wide range of sample types, such as cell lysates, tissue extracts, and biological fluids.

The THC2 Polyclonal Antibody offers researchers a valuable tool for studying the role of THC2 in various biological processes and diseases. Its exceptional performance characteristics make it an ideal choice for both basic research and clinical applications. Trust in the THC2 Polyclonal Antibody to provide accurate and reliable results, advancing your scientific investigations.